Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Rosager Dental A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2%   Bankruptcy risk   15.4% 10.2% 14.3% 9.6% 20.0% 35.5% 20.6% 17.3%   Credit score (0-100)   15 25 16 26 5 0 4 9   Credit rating   BB BB BB BB B C B BB   Credit limit (kDKK)   0.0 -0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   6,467 0 0 0 0 0 0 0   Gross profit   3,082 1,728 348 256 219 81.3 0.0 0.0   EBITDA   262 51.3 301 248 130 314 0.0 0.0   EBIT   247 46.3 301 248 130 198 0.0 0.0   Pre-tax profit (PTP)   151.1 -28.7 262.8 234.3 122.8 195.7 0.0 0.0   Net earnings   151.1 -28.7 262.8 234.3 122.8 179.2 0.0 0.0   Pre-tax profit without non-rec. items   151 -28.7 263 234 123 196 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   64.7 9.9 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -691 -720 -457 -223 -99.9 79.3 -421 -421   Interest-bearing liabilities   932 777 585 485 0.0 0.0 421 421   Balance sheet total (assets)   1,079 107 165 293 7.6 171 0.0 0.0   Net Debt   928 762 531 485 -7.6 -48.3 421 421     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   6,467 0 0 0 0 0 0 0   Net sales growth   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,082 1,728 348 256 219 81.3 0.0 0.0   Gross profit growth   9.0% -43.9% -79.9% -26.5% -14.3% -62.9% -100.0% 0.0%   Employees   7 0 1 1 1 0 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,079 107 165 293 8 171 0 0   Balance sheet change%   5.9% -90.1% 53.9% 77.8% -97.4% 2,148.4% -100.0% 0.0%   Added value   262.3 51.3 301.3 247.6 129.6 314.4 0.0 0.0   Added value %   4.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -31 -60 -10 0 0 -117 0 0   Net sales trend   0.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   4.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   3.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.0% 2.7% 86.7% 96.9% 59.1% 243.4% 0.0% 0.0%   Net Earnings %   2.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   2.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.6% 3.6% 41.8% 45.8% 41.8% 142.2% 0.0% 0.0%   ROI %   24.8% 5.4% 44.5% 48.7% 53.8% 499.0% 0.0% 0.0%   ROE %   14.4% -4.8% 193.1% 102.2% 81.6% 412.6% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   -39.0% -87.0% -73.5% -43.2% -92.9% 46.5% -100.0% -100.0%   Relative indebtedness %   27.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   27.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   353.9% 1,485.8% 176.2% 195.7% -5.9% -15.4% 0.0% 0.0%   Gearing %   -134.8% -107.9% -128.1% -217.5% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.6% 8.8% 5.9% 4.9% 3.2% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.3 0.1 0.3 0.6 0.1 1.9 0.0 0.0   Current Ratio   0.6 0.1 0.3 0.6 0.1 1.9 0.0 0.0   Cash and cash equivalent   3.5 14.2 54.5 0.0 7.6 48.3 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   15.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -755.8 -729.8 -457.0 -222.8 -99.9 79.3 -210.4 -210.4   Net working capital %   -11.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   924 0 0 0 0 0 0 0   Added value / employee   37 0 301 248 130 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   37 0 301 248 130 0 0 0   EBIT / employee   35 0 301 248 130 0 0 0   Net earnings / employee   22 0 263 234 123 0 0 0